See more : Globe Life Inc. 4.25% Junior Su (GL-PD) Income Statement Analysis – Financial Results
Complete financial analysis of Forian Inc. (FORA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Forian Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Zorlu Enerji Elektrik Üretim A.S. (ZOREN.IS) Income Statement Analysis – Financial Results
- CHYY Development Group Limited (8128.HK) Income Statement Analysis – Financial Results
- Windward Ltd. (WNWD.L) Income Statement Analysis – Financial Results
- Spectrum Pharmaceuticals, Inc. (SPPI) Income Statement Analysis – Financial Results
- Haleon plc (HLNCF) Income Statement Analysis – Financial Results
Forian Inc. (FORA)
About Forian Inc.
Forian Inc. provides software solutions, proprietary data driven insights, and predictive analytics to optimize the operational, clinical, and financial performance of its healthcare, cannabis, and government customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides clients with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain; and STEMS, a seed-to-sale tracking module, to provide cannabis program management solution to cannabis regulatory agencies. In addition, the company offers security monitoring and web marketing services. The company is headquartered in Newtown, Pennsylvania.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 20.48M | 28.01M | 16.88M | 544.87K | 0.00 |
| Cost of Revenue | 5.48M | 6.87M | 4.72M | 38.29K | 854.00 |
| Gross Profit | 15.00M | 21.13M | 12.16M | 506.58K | -854.00 |
| Gross Profit Ratio | 73.26% | 75.45% | 72.05% | 92.97% | 0.00% |
| Research & Development | 1.41M | 12.35M | 8.98M | 2.51M | 827.47K |
| General & Administrative | 13.63M | 20.53M | 23.46M | 2.98M | 0.00 |
| Selling & Marketing | 4.88M | 5.87M | 4.14M | 573.85K | 0.00 |
| SG&A | 18.52M | 26.40M | 27.61M | 2.98M | 463.84K |
| Other Expenses | 674.27K | 2.89M | 1.99M | 0.00 | 0.00 |
| Operating Expenses | 20.60M | 41.64M | 38.57M | 5.49M | 1.29M |
| Cost & Expenses | 26.08M | 48.51M | 43.29M | 5.53M | 1.29M |
| Interest Income | 2.33M | 267.13K | 6.81K | 3.57K | 5.00K |
| Interest Expense | 834.79K | 873.34K | 322.38K | 0.00 | 0.00 |
| Depreciation & Amortization | 96.33K | 67.18K | 2.21M | 8.56K | 854.00 |
| EBITDA | 2.75M | -18.25M | -24.00M | -4.97M | -1.29M |
| EBITDA Ratio | 13.43% | -61.01% | -143.31% | -913.75% | 0.00% |
| Operating Income | -5.60M | -20.51M | -26.41M | -4.98M | -1.29M |
| Operating Income Ratio | -27.32% | -73.23% | -156.44% | -914.67% | 0.00% |
| Total Other Income/Expenses | 7.41M | -215.20K | 1.09M | 3.57K | 3.33K |
| Income Before Tax | 1.82M | -25.95M | -26.53M | -4.98M | -1.29M |
| Income Before Tax Ratio | 8.88% | -92.65% | -157.16% | -914.01% | 0.00% |
| Income Tax Expense | 85.74K | 23.98K | 22.51K | -3.57K | -4.00 |
| Net Income | 11.11M | -25.97M | -26.55M | -4.98M | -1.29M |
| Net Income Ratio | 54.23% | -92.74% | -157.30% | -913.36% | 0.00% |
| EPS | 0.35 | -0.81 | -0.84 | -0.17 | -0.04 |
| EPS Diluted | 0.34 | -0.81 | -0.84 | -0.17 | -0.04 |
| Weighted Avg Shares Out | 32.03M | 32.03M | 31.77M | 29.82M | 29.82M |
| Weighted Avg Shares Out (Dil) | 32.23M | 32.03M | 31.77M | 29.82M | 29.82M |
VerticalScope Announces Fourth Quarter and Full Year 2022 Financial Results
Forian sells cannabis software unit BioTrack to venture capital-backed Alleaves
Forian Announces the Sale of BioTrack to Alleaves
VerticalScope Announces Changes to the Board and Appointment of Rob Laidlaw as Chair
VerticalScope Announces Changes to the Board and Appointment of Rob Laidlaw as Chair
VerticalScope Announces Organizational Changes and Reports Preliminary Unaudited Fourth Quarter and Full Year 2022 Results
VerticalScope Announces Organizational Changes and Reports Preliminary Unaudited Fourth Quarter and Full Year 2022 Results
VerticalScope to Announce Fourth Quarter and Full Year 2022 Results
VerticalScope to Announce Fourth Quarter and Full Year 2022 Results
VerticalScope to Announce Fourth Quarter and Full Year 2022 Results
Source: https://incomestatements.info
Category: Stock Reports